NCT00167986已完成不适用
Antibiotic Intervention Trial in a Medical Intensive Care Unit to Reduce the Acquisition of Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae.
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 480 人开始时间: 2005年1月最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 480
研究概览
简要总结
To determine whether the restriction of 3rd generation cephalosporins and carbapenems contribute to the reduction of intestinal colonization or infection with vancomycin-resistant enterococci (VRE) in a medical intensive care unit (MICU).
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients admitted to or transferred to the MICU.
- •Patients 18 years of age or older.
- •Provide written informed consent.
排除标准
- •Patients known to be infected or colonized by VRE or ESBL-producing E.coli, K.pneumoniae.
- •Patients who have hypersensitivity to penicillin.
- •Any underlying conditions or diseases that will be ultimately fatal within 48 hours.
- •Any concurrent condition or medication which would interfere with absorption or metabolism of study drugs.
研究者
相似试验
尚未招募
3 期
A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened LaborPreviable Labour With Intact MembranesNCT06572761Assistance Publique - Hôpitaux de Paris350
已完成
4 期
Study Evaluation Tazocin InterventionBacterial InfectionsNCT00488189Wyeth is now a wholly owned subsidiary of Pfizer134
已完成
不适用
Study of Adverse Effects Occuring in Patients Receiving an Antibiotic Treatment With TemocillinBacterial Infection With One or More Extended Spectrum Betalactamases Remaining Susceptible to TemocillinNCT03599999Centre Hospitalier Universitaire, Amiens26
已完成
3 期
Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV TransmissionHIV InfectionsNCT00021671National Institute of Allergy and Infectious Diseases (NIAID)3,720
Unknown
不适用
Preventing Infections in Orthopaedic PatientsOpen FractureNCT02948387Olayemi Osiyemi MD50